What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Disease
- Myocardial infarction
Vera Bittner mainly investigates Internal medicine, Myocardial infarction, Physical therapy, Cardiology and Surgery.
Her work on Endocrinology expands to the thematically related Internal medicine.
Her studies in Myocardial infarction integrate themes in fields like Statin, Stroke, Chest pain, Hazard ratio and Hormone replacement therapy.
Her Physical therapy study combines topics in areas such as Intervention, Disease, Unstable angina and Depression.
Her work in the fields of Cardiology, such as Ejection fraction, overlaps with other areas such as In patient.
Her studies deal with areas such as Gastroenterology, Cause of death, Placebo, Case fatality rate and Heart disease as well as Surgery.
Her most cited work include:
- Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II) (1601 citations)
- HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events (1273 citations)
- Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association (1218 citations)
What are the main themes of her work throughout her whole career to date?
Vera Bittner mostly deals with Internal medicine, Cardiology, Myocardial infarction, Coronary artery disease and Physical therapy.
Her Internal medicine research incorporates elements of Diabetes mellitus, Endocrinology and Alirocumab.
Her research integrates issues of Randomized controlled trial and Hazard ratio in her study of Cardiology.
Her Myocardial infarction research incorporates themes from Stroke, Statin and Emergency medicine.
Vera Bittner interconnects Surgery, Chest pain, Ischemia, Angina and Risk factor in the investigation of issues within Coronary artery disease.
Her Physical therapy research is multidisciplinary, incorporating perspectives in Psychosocial, Disease and Depression.
She most often published in these fields:
- Internal medicine (69.53%)
- Cardiology (37.12%)
- Myocardial infarction (22.53%)
What were the highlights of her more recent work (between 2018-2021)?
- Internal medicine (69.53%)
- Cardiology (37.12%)
- Alirocumab (9.23%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Internal medicine, Cardiology, Alirocumab, Acute coronary syndrome and Myocardial infarction.
Her study in Internal medicine focuses on PCSK9, Cholesterol, Lipoprotein, Lipoprotein and Hazard ratio.
Her Cardiology research includes elements of Disease and Ischemic stroke.
Her Disease course of study focuses on Diabetes mellitus and Kidney disease.
Her Myocardial infarction study integrates concerns from other disciplines, such as Relative risk and Adverse effect.
The concepts of her Coronary artery disease study are interwoven with issues in Myocardial ischemia and Ischemia.
Between 2018 and 2021, her most popular works were:
- Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial (84 citations)
- Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome. (82 citations)
- Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial. (64 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Myocardial infarction
Her primary areas of investigation include Internal medicine, Alirocumab, Cardiology, Acute coronary syndrome and Myocardial infarction.
Her Internal medicine research focuses on Cholesterol, Statin, Statin treatment, Kidney disease and Disease.
Her biological study spans a wide range of topics, including Smoking cessation, Lifestyle management, Intensive care medicine, Sedentary lifestyle and Social determinants of health.
Vera Bittner combines subjects such as Stroke, Lipoprotein and Reactivity with her study of Cardiology.
Vera Bittner has included themes like Proprotein convertase, Placebo, PCSK9 and Secondary prevention in her Acute coronary syndrome study.
Her study in the fields of Unstable angina under the domain of Myocardial infarction overlaps with other disciplines such as Task force.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
